Relevant bibliographies by topics / Metachronous metastasis

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters
  4. Conference papers

Academic literature on the topic 'Metachronous metastasis'

Author: Grafiati
Published: 4 June 2021
Last updated: 17 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Metachronous metastasis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Metachronous metastasis"

1

QUIREZE JUNIOR, Claudemiro, Andressa Machado Santana BRASIL, Lúcio Kenny MORAIS, Edmond Raymond Le CAMPION, Eliseu José Fleury TAVEIRA, and Matheus Castrillon RASSI. "METACHRONOUS COLORECTAL LIVER METASTASES HAS BETTER PROGNOSIS - IS IT TRUE?" Arquivos de Gastroenterologia 55, no. 3 (2018): 258–63. http://dx.doi.org/10.1590/s0004-2803.201800000-64.

Full text
Abstract:
ABSTRACT BACKGROUND: Liver metastases from colorectal cancer are an important public health problem due to the increasing incidence of colorectal cancer worldwide. Synchronous colorectal liver metastasis has been associated with worse survival, but this prognosis is controversial. OBJECTIVE: The objective of this study was to evaluate the recurrence-free survival and overall survival between groups of patients with metachronous and synchronous colorectal hepatic metastasis. METHODS: This was a retrospective analysis of medical records of patients with colorectal liver metastases seen from 2013
APA, Harvard, Vancouver, ISO, and other styles
2

Tanvetyanon, Tawee, Lary A. Robinson, Michael J. Schell, et al. "Outcomes of Adrenalectomy for Isolated Synchronous Versus Metachronous Adrenal Metastases in Non–Small-Cell Lung Cancer: A Systematic Review and Pooled Analysis." Journal of Clinical Oncology 26, no. 7 (2008): 1142–47. http://dx.doi.org/10.1200/jco.2007.14.2091.

Full text
Abstract:
Purpose Several small studies have reported that an adrenalectomy for isolated adrenal metastasis in non–small-cell lung cancer (NSCLC), along with a surgical resection for the primary lung cancer, can be curative. However, some suggest that the survival outcome among patients with a synchronous metastasis is poor. It remains unclear whether this treatment approach is warranted among those with synchronous metastasis. Methods A search for publications on adrenalectomy for NSCLC was performed via the MEDLINE database. Studies reporting on survival outcomes and containing at least four analyzabl
APA, Harvard, Vancouver, ISO, and other styles
3

Thornblade, Lucas W., Ernest Han, and Yuman Fong. "Colorectal cancer ovarian metastases." International Journal of Gynecologic Cancer 31, no. 8 (2021): 1137–44. http://dx.doi.org/10.1136/ijgc-2020-002328.

Full text
Abstract:
ObjectiveOvarian metastases occur in 3%–5% of patients with colorectal cancer. The role of oophorectomy in that setting continues to be debated. We aimed to assess the survival of women treated with metastasectomy for ovarian metastasis.MethodsRetrospective cohort study of patients in the California Cancer Registry (2000–2012) with stage IV colorectal cancer and ovarian metastases. Pathology other than adenocarcinoma was excluded. Adjusted Cox-proportional hazard analysis was applied to assess the risk of death.ResultsA total of 756 patients with synchronous ovarian metastases and 516 patients
APA, Harvard, Vancouver, ISO, and other styles
4

Voß, Hannah, Marcus Wurlitzer, Daniel J. Smit, et al. "Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer." Clinical & Experimental Metastasis 37, no. 6 (2020): 649–56. http://dx.doi.org/10.1007/s10585-020-10058-8.

Full text
Abstract:
AbstractColorectal cancer (CRC) patients suffer from the second highest mortality among all cancer entities. In half of all CRC patients, colorectal cancer liver metastases (CRLM) can be observed. Metastatic colorectal cancer is associated with poor overall survival and limited treatment options. Even after successful surgical resection of the primary tumor, metachronous liver metastases occur in one out of eight cases. The only available curative intended treatment is hepatic resection, but metachronous CRLM frequently recur after approximately 1 year. In this study, we performed a proteome a
APA, Harvard, Vancouver, ISO, and other styles
5

Thrumurthy, SG, AM Jadav, M. Pitt, et al. "Metachronous bilateral adrenal metastases following curative treatment for colorectal carcinoma." Annals of The Royal College of Surgeons of England 93, no. 6 (2011): e96-e98. http://dx.doi.org/10.1308/147870811x591134.

Full text
Abstract:
A delayed, metachronous presentation of bilateral adrenal metastases following colorectal cancer has never previously been reported. We describe the case of a 68-year-old man who underwent curative surgery and adjuvant chemotherapy for a locally invasive sigmoid adenocarcinoma, only to be diagnosed with metachronous bilateral adrenal metastasis necessitating further resection and chemotherapy. We discuss the literature surrounding this pathology and highlight the importance of continual, vigilant radiological surveillance of the adrenal glands after curative treatment of colorectal carcinoma w
APA, Harvard, Vancouver, ISO, and other styles
6

Imano, Motohiro, Kiyotaka Okuno, Tatsuki Itoh, et al. "Osteopontin Induced by Macrophages Contribute to Metachronous Liver Metastases in Colorectal Cancer." American Surgeon 77, no. 11 (2011): 1515–20. http://dx.doi.org/10.1177/000313481107701143.

Full text
Abstract:
Even after radical surgery for stage II and stage III colorectal cancer, metachronous liver metastasis is frequently observed. The aim of this study was to identify the risk of metachronous liver metastasis with retrospective clinicopathological study. Immunohistochemistry was performed to evaluate the expression of Osteopontin (OPN), CD-68, and CD105 in 41 cases of stage II and stage III colorectal cancer tissue. Stage II and stage III colorectal cancer patients who had undergone R0 resection were classified into two groups: with metachronous liver metastasis (m-LM; n = 17) and without liver
APA, Harvard, Vancouver, ISO, and other styles
7

De Groote, Ruben, Alessandro Larcher, Marijn Goossens, et al. "Metachronous metastasis of renal cell carcinoma to the urinary bladder: a case report." Therapeutic Advances in Urology 10, no. 1 (2017): 29–32. http://dx.doi.org/10.1177/1756287217738986.

Full text
Abstract:
We report a case of intravesical metastasis of a clear cell renal cell carcinoma. In renal cell carcinoma 16% of patients present with metastatic disease. Renal cell carcinoma can metastasize to nearly every organ, although metastatic spread to the urinary bladder is rare, with fewer than 70 described cases. The route and pattern of metastatic spread is not yet fully understood and different pathways are suggested. Gross haematuria is the presenting symptom in the majority of cases. These intravesical metastases may be synchronous or metachronous and can be solitary or part of polymetastatic d
APA, Harvard, Vancouver, ISO, and other styles
8

Gurbuz, A., G. Kir, A. Karateke, B. Haliloglu, and C. Kabaca. "Metastatic ovarian carcinoma one year after surgical removal of colon carcinoma during pregnancy: a case report." International Journal of Gynecologic Cancer 16, Suppl 1 (2006): 330–33. http://dx.doi.org/10.1136/ijgc-00009577-200602001-00057.

Full text
Abstract:
Colorectal carcinoma during pregnancy is a very rare event. We presented a woman with metachronous metastatic ovarian tumor existing 1 year after surgical removal of perforated sigmoid colon carcinoma encountered during cesarean section of woman of 36-week gestation for fetal distress. Pregnant women with suspicious abdominal mass should be evaluated for a possible colorectal carcinoma even in the absence of any other gastrointestinal symptoms associated with it and undergo rectal examination and sigmoidoscopy. In addition, as synchronous and metachronous ovarian metastases are common in these
APA, Harvard, Vancouver, ISO, and other styles
9

Markovic, Marina, Dalibor Jovanovic, Zeljko Todorovic, et al. "Primary Small Cell Carcinoma Of Lung With Metachronous Breast Metastasis." Serbian Journal of Experimental and Clinical Research 18, no. 3 (2017): 263–67. http://dx.doi.org/10.1515/sjecr-2016-0087.

Full text
Abstract:
Abstract Breast metastases from an extra-mammary malignancy are rare. Among the lung malignancies that metastasise in the breasts, previous literature has described approximately 30 cases of NSCLC and only a few cases of SCLC. Here, we present a 54-year-old woman with metachronous breast metastasis from pulmonary small cell carcinoma. She presented with a soft tissue mass in the right lung hilum. After bronchoscopy with biopsy, SCLC was verified. Th e patient was given 4 cycles of etoposide and cisplatin followed by radiation therapy. Seven months after the diagnosis of primary lung cancer, th
APA, Harvard, Vancouver, ISO, and other styles
10

Miller, G., P. Biernacki, N. Kemeny, et al. "Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases." Journal of Clinical Oncology 25, no. 18_suppl (2007): 4059. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.4059.

Full text
Abstract:
4059 Background: Surgical resection of isolated hepatic or pulmonary colorectal metastases prolongs survival in selected patients. However, the benefits of resection and appropriate selection criteria in patients who develop both hepatic and pulmonary metastases are ill-defined. Methods: Data were prospectively collected from 131 patients with colorectal cancer who underwent resection of both hepatic and pulmonary metastases over a 20-year period. Median follow-up was 6.6 years from the time of resection of the primary tumor. Patient, treatment, and outcome variables were analyzed using log-ra
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Metachronous metastasis"

1

Kammerer-Jacquet, Solène-Florence. "Carcinome à cellules claires du rein : phénotype métastatique et résistance aux thérapies ciblées." Thesis, Rennes 1, 2016. http://www.theses.fr/2016REN1B038.

Full text
Abstract:
Le carcinome rénal à cellules claires (ccRCC) est la tumeur du rein la plus fréquente. Il se caractérise par une inactivation fréquente du gène suppresseur de tumeur VHL retrouvée dans 70% des tumeurs conduisant à une transcription des gènes cibles du facteur de transcription HIF dont le VEGF. Il s’agit d’une tumeur agressive métastatique chez 50% des patients. Le sunitinib, un inhibiteur des récepteurs tyrosine kinase anti-angiogénique, est actuellement le plus utilisé en 1ère ligne malgré 30% des patients qui progressent rapidement. L’avènement d’un nouvel anti-angiogénique ciblant MET (cabo
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Metachronous metastasis"

1

Waechter, Fábio Luiz, Uirá Fernandes Teixeira, Pablo Duarte Rodrigues, Marcio Boff, Rinaldo Danesi, and Mauro Monteiro Correia. "Resection of Metachronous Colorectal Cancer Liver Metastases: Surgical Outcomes." In Colorectal Cancer Liver Metastases. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-25486-5_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Metachronous metastasis"

1

Naeini, Marjan Mojtabavi, Neha Rohatgi, Umesh Ghoshdastider, Ari A. Hakimi, and Anders Jacobsen Skanderup. "Abstract LB241: Genomic and molecular features of metachronous metastasis in clear cell renal cell carcinoma." In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-lb241.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Driouch, Keltouma, Zakia Tariq, Sylvain Baulande, et al. "Abstract 3440: Genomic evolution of synchronous and metachronous breast cancer metastasis revealed from a prospective clinical trial." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-3440.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tuyls, S., O. Brouckaert, A. Vanderstichele, et al. "Abstract P6-05-05: Triple receptor comparison between primary breast cancer and metachronous or synchronous liver metastasis." In Abstracts: Thirty-Fifth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 4‐8, 2012; San Antonio, TX. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/0008-5472.sabcs12-p6-05-05.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Xiao, C., X. Qi, A. Chen, W. Zhang, P. Zhang, and X. Cao. "Abstract P2-12-15: The role of neck dissection in breast cancer patients with synchronous and metachronous ipsilateral supraclavicular lymph node metastasis." In Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.sabcs15-p2-12-15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nakamura, Ayako, Kazuhiko Hayashi, Go Nakajima, et al. "Abstract 5249: Analysis of gene expression levels associating with metabolism of 5-fluorouracil and folate in primary colorectal cancer and corresponding synchronous or metachronous liver metastasis." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-5249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ghidhaoui, A., A. Staebler, J. Schittenhelm, S. Brucker, and C. Bachmann. "EP855 Metachronous brain metastases in ovarian cancer." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.904.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ghidhaoui, A., A. Staebler, J. Schittenhelm, and C. Bachmann. "Metachronous brain metastases in ovarian cancer: analysis of Her1-4." In Kongressabstracts zur Tagung 2020 der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). © 2020. Thieme. All rights reserved., 2020. http://dx.doi.org/10.1055/s-0040-1718138.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Dietmaier, Wolfgang, Alexander Kiesl, Corinna Lang-Schwarz, Petra Ruemmele, Benedikt Groeschl, and Ferdinand Hofstaedter. "Abstract 2351: Evaluation of KRAS and BRAF mutation analysis in primary metastatic colorectal cancers versus matched syn- and metachronous metastases." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-2351.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wang, Hongfei, and Xiadong Lv. "Mining raw gene expression microarray data for analyzing synchronous and metachronous liver metastatic lesions from colorectal cancer." In 2016 9th International Congress on Image and Signal Processing, BioMedical Engineering and Informatics (CISP-BMEI). IEEE, 2016. http://dx.doi.org/10.1109/cisp-bmei.2016.7853014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Metachronous metastasis' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography